Get started
Author

Pieter H.E. Groot

Observed names: P GROOT, P Groot, P H E Groot, P H Groot, P. Groot, P. H. E. GROOT, P. H. E. Groot, P. H. GROOT, P. H.E. Groot, P.H.E Groot, P.H.E. GROOT, P.H.E. Groot, PIETER H. E. GROOT, Pieter Groot, Pieter H E Groot, Pieter H Groot, Pieter H. E. GROOT, Pieter H. E. Groot, Pieter H. Groot, Pieter H.E Groot, Pieter HE Groot
Observed institutions: University of North Carolina at Chapel Hill, Leiden University, Netherlands Organisation for Applied Scientific Research, University of Graz, The University of Queensland, GlaxoSmithKline (United Kingdom), Esperion Therapeutics (United States), Leiden University Medical Center, The Royal Free Hospital, Erasmus MC, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, Maastricht University, GlaxoSmithKline (United States), Erasmus MC - Sophia Children’s Hospital, GlaxoSmithKline Research & Development Limited (United Kingdom), University College London, University of Pennsylvania, University of Amsterdam, University of Sheffield, Erasmus University Rotterdam
OpenAlex ID: A5111831730
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
1991 · P H Groot, W A van Stiphout, et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 531
Chemokines and atherosclerosis
1999 · Theresa J Reape, Pieter H.E Groot · Atherosclerosis · 508
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
2016 · Stephen L. Pinkosky, Roger S. Newton, et al. · Nature Communications · 506
PDF
Fatty Acid Activation: Specificity, Localization, and Function
1976 · P.H.E. GROOT, H.R. SCHOLTE, et al. · Advances in lipid research · 215
Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1
2004 · Jelske N. van der Veen, Janine K. Kruit, et al. · Journal of Lipid Research · 188
Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice
2005 · Janine K. Kruit, Torsten Plösch, et al. · Gastroenterology · 168
PDF
Fractalkine Is Expressed by Smooth Muscle Cells in Response to IFN-γ and TNF-α and Is Modulated by Metalloproteinase Activity
2002 · Andreas Ludwig, Theo Berkhout, et al. · The Journal of Immunology · 148
PDF
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids
1998 · Nigel J. PEARCE, John W. YATES, et al. · Biochemical Journal · 148
PDF
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice
1994 · Janine H. van Ree, Walther J.A.A. van den Broek, et al. · Atherosclerosis · 147
Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age.
1990 · N A Elshourbagy, J C Near, et al. · Journal of Biological Chemistry · 129
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean andob/obmice
2005 · Aldo Grefhorst, Theo H. van Dijk, et al. · American Journal of Physiology-Endocrinology and Metabolism · 126
Synthetic LXR agonists increase LDL in CETP species
2005 · Pieter H.E. Groot, Nigel J. Pearce, et al. · Journal of Lipid Research · 123
Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis
2000 · Miranda Van Eck, Robert Zimmermann, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 122
Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man
1980 · Jantine H. Brussaard, Geesje Dallinga-Thie, et al. · Atherosclerosis · 119
Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders
2017 · Stephen L. Pinkosky, Pieter H.E. Groot, et al. · Trends in Molecular Medicine · 118
Expression and Cellular Localization of the CC Chemokines PARC and ELC in Human Atherosclerotic Plaques
1999 · Theresa J. Reape, Kim Rayner, et al. · American Journal Of Pathology · 118
PDF
Quantitative Assessment of Aortic Atherosclerosis in APOE*3 Leiden Transgenic Mice and Its Relationship to Serum Cholesterol Exposure
1996 · Pieter H.E. Groot, Bart J.M. van Vlijmen, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 112
Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months
1982 · Jantine H. Brussaard, Martijn B. Katan, et al. · Atherosclerosis · 98
Bone Marrow Transplantation in Apolipoprotein E–Deficient Mice
1997 · Miranda Van Eck, Nicole Herijgers, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 95
Cloning, in Vitro Expression, and Functional Characterization of a Novel Human CC Chemokine of the Monocyte Chemotactic Protein (MCP) Family (MCP-4) That Binds and Signals through the CC Chemokine Receptor 2B
1997 · Theo A. Berkhout, Henry M. Sarau, et al. · Journal of Biological Chemistry · 92
CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach
2003 · Theo A. Berkhout, Frank E. Blaney, et al. · Journal of Medicinal Chemistry · 91
Cloning and expression of a human ATP‐citrate lyase cDNA
1992 · Nabil A. ELSHOURBAGY, Joseph C. NEAR, et al. · European Journal of Biochemistry · 85
PDF
The effect of (−)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2
1990 · T A Berkhout, L M Havekes, et al. · Biochemical Journal · 79
PDF
Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery Calcification
2002 · Ana M. Valdes, Megan L. Wolfe, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 78
Transplantation of Monocyte CC-Chemokine Receptor 2–Deficient Bone Marrow Into ApoE3–Leiden Mice Inhibits Atherogenesis
2003 · Jian Guo, Miranda Van Eck, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 72
Works count: 113
Citation count: 6,298
H-index: 43
I10-index: 84
Year
Topic
Type